GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Remus Pharmaceuticals Ltd (NSE:REMUS) » Definitions » 5-Year Yield-on-Cost %

Remus Pharmaceuticals (NSE:REMUS) 5-Year Yield-on-Cost % : 0.10 (As of May. 02, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Remus Pharmaceuticals 5-Year Yield-on-Cost %?

Remus Pharmaceuticals's yield on cost for the quarter that ended in Sep. 2024 was 0.10.


The historical rank and industry rank for Remus Pharmaceuticals's 5-Year Yield-on-Cost % or its related term are showing as below:

NSE:REMUS' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.04   Med: 0.05   Max: 0.11
Current: 0.1


During the past 4 years, Remus Pharmaceuticals's highest Yield on Cost was 0.11. The lowest was 0.04. And the median was 0.05.


NSE:REMUS's 5-Year Yield-on-Cost % is ranked worse than
100% of 68 companies
in the Medical Distribution industry
Industry Median: 3.66 vs NSE:REMUS: 0.10

Competitive Comparison of Remus Pharmaceuticals's 5-Year Yield-on-Cost %

For the Medical Distribution subindustry, Remus Pharmaceuticals's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Remus Pharmaceuticals's 5-Year Yield-on-Cost % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Remus Pharmaceuticals's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Remus Pharmaceuticals's 5-Year Yield-on-Cost % falls into.


;
;

Remus Pharmaceuticals 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Remus Pharmaceuticals is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Remus Pharmaceuticals  (NSE:REMUS) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Remus Pharmaceuticals 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Remus Pharmaceuticals's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Remus Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Ambli bopal Road, 1101 to 1103, South Tower, One 42, Behind Ashok Vatika, Near Jayantilal Park BRTS, Ahmedabad, GJ, IND, 380054
Remus Pharmaceuticals Ltd is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries. Remus Pharmaceuticals market niche medicinal combinations. It exports generic drugs by conducting intensive market research in the pharmaceutical industry to expand its product portfolio.

Remus Pharmaceuticals Headlines

No Headlines